CYTOKINETICS, INCORPORATED Public Float
CYTOKINETICS, INCORPORATED (CYTK) had Public Float of $2.50 billion as of 2025-06-30, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-26
- 2025-06-30: Entity Public Float $2.50B.
- 2024-06-28: Entity Public Float $5.60B.
- 2023-06-30: Entity Public Float $2.00B.
- 2022-06-30: Entity Public Float $2.00B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $2.50B 10-K · filed 2026-02-26 |
| 2024-06-28 | $5.60B 10-K · filed 2025-02-27 |
| 2023-06-30 | $2.00B 10-K · filed 2024-02-28 |
| 2022-06-30 | $2.00B 10-K · filed 2023-03-01 |
| 2021-06-30 | $1.44B 10-K · filed 2022-02-25 |
| 2020-06-30 | $1.41B 10-K · filed 2021-02-26 |
| 2019-06-28 | $653.10M 10-K · filed 2020-03-04 |
| 2018-06-29 | $449.70M 10-K · filed 2019-03-07 |
| 2017-06-30 | $630.80M 10-K · filed 2018-03-05 |
| 2016-06-30 | $375.50M 10-K · filed 2017-03-06 |
| 2015-06-30 | $259.60M 10-K · filed 2016-03-03 |
| 2014-06-30 | $174.50M 10-K · filed 2015-03-06 |
| 2013-06-28 | $331.20M 10-K · filed 2014-03-07 |
| 2012-06-29 | $83.20M 10-K · filed 2013-03-15 |
| 2011-06-30 | $85.80M 10-K · filed 2012-03-13 |
| 2010-06-30 | $118.20M 10-Q · filed 2011-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |